GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Other Long-Term Liabilities

NewAmsterdam Pharma Co NV (FRA:KH6) Other Long-Term Liabilities : €7.14 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Other Long-Term Liabilities?

NewAmsterdam Pharma Co NV's other long-term liabilities for the quarter that ended in Dec. 2023 was €7.14 Mil.

NewAmsterdam Pharma Co NV's quarterly other long-term liabilities increased from Dec. 2022 (€7.10 Mil) to Jun. 2023 (€7.58 Mil) but then declined from Jun. 2023 (€7.58 Mil) to Dec. 2023 (€7.14 Mil).

NewAmsterdam Pharma Co NV's annual other long-term liabilities increased from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€7.10 Mil) and increased from Dec. 2022 (€7.10 Mil) to Dec. 2023 (€7.14 Mil).

NewAmsterdam Pharma Co NV Other Long-Term Liabilities Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Other Long-Term Liabilities Chart

NewAmsterdam Pharma Co NV Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
- - - -

NewAmsterdam Pharma Co NV Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Long-Term Liabilities Get a 7-Day Free Trial - - - - -

NewAmsterdam Pharma Co NV Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

NewAmsterdam Pharma Co NV Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (FRA:KH6) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Other Long-Term Liabilities
Comparable Companies
MDXG VERV AKRO ADMA ICPT SLNO INVA OLMA NVAX COGT OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
NAMS:USA KH6:Germany
Address
Gooimeer 2-35, Naarden, NH, NLD, 1411 DC
Website
https://www.newamsterdampharma.com
NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

NewAmsterdam Pharma Co NV (FRA:KH6) Headlines

No Headlines